文献速递生殖医学产科

抗苗勒管激素水平显著升高与多囊卵巢综合征患者促排卵后早产相关

Highly elevated level of antimüllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction.
PubMed 文献 · Fertil Steril · 2020-09-01

该研究为两项多中心随机临床试验(PPCOS II 与 AMIGOS)数据的二次分析,纳入118例多囊卵巢综合征(PCOS)女性和146例不明原因不孕女性,评估促排卵后活产中抗苗勒管激素(AMH)与自发性早产的关系。PCOS人群中AMH每升高1单位,早产风险增加14%(OR 1.14,95%CI 1.02-1.26),校正后为25%(aOR 1.25,95%CI 1.06-1.49);不明原因不孕人群中无显著差异。

要点

  • PCOS促排卵后早产者AMH中位11.1 ng/mL,足月者5.4 ng/mL。
  • PCOS人群中AMH每升高1单位,早产风险增加14%(OR 1.14,95%CI 1.02-1.26)。
  • 不明原因不孕人群中早产与足月者AMH无显著差异(2.3 vs. 2.6 ng/mL)。

核心结论

  • 研究提示,促排卵后受孕且AMH水平高的PCOS女性为早产高风险群体。
  • 作者认为,对孕早期AMH高于9.3 ng/mL的PCOS孕妇,孕晚期更密切监测可能是有理由的。

研究设计与样本

  • 两项多中心随机临床试验(PPCOS II 与 AMIGOS)数据的二次分析。
  • 评估PPCOS II队列(n=172)和AMIGOS队列(n=222)中≥24周活产,排除医源性早产风险者后,最终纳入PCOS女性118例和不明原因不孕女性146例。

主要发现

  • PCOS人群总体AMH中位5.5 ng/dL(四分位距2.9-9.3 ng/dL)。
  • PCOS早产者中62%的AMH高于第75百分位。
  • PCOS早产者AMH高于足月者(11.1 vs. 5.4 ng/mL)。
  • PCOS单变量逻辑回归中,AMH每升高1单位早产风险增加14%(OR 1.14,95%CI 1.02-1.26);校正年龄、种族、BMI、吸烟状态、睾酮、HOMA-IR及治疗随机分组后为25%(aOR 1.25,95%CI 1.06-1.49)。
  • 不明原因不孕人群中,早产与足月者AMH无显著差异(2.3 vs. 2.6 ng/mL)。

临床怎么用

  • 作者认为,对孕早期AMH高于9.3 ng/mL的PCOS孕妇,孕晚期更密切监测可能是有理由的。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine the relationship between high antimüllerian hormone (AMH) levels and increased preterm delivery risk in populations of women with polycystic ovary syndrome (PCOS) or unexplained infertility undergoing ovulation induction. DESIGN: Secondary analysis of data from two multicenter randomized clinical trials: Pregnancy in Polycystic Ovary Syndrome II (PPCOS II); and Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation (AMIGOS). SETTING: Not applicable. PATIENTS: Live births at ≥24 weeks' gestation from both the PPCOS II (n = 172) and AMIGOS (n = 222) cohorts were evaluated, and those at risk for iatrogenic preterm delivery including placental conditions, fetal growth restriction, multiple gestations, hypertensive diseases of pregnancy, and pre-gestational diabetes were excluded. The final analysis included 118 women with PCOS from the PPCOS II cohort and 146 women with unexplained infertility from the AMIGOS cohort. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): Spontaneous preterm delivery. RESULTS: In the PCOS population, median AMH overall was 5.5 ng/dL (interquartile range 2.9-9.3 ng/dL). In all, 62% of participants who delivered preterm had AMH levels above the 75th percentile. When comparing clinical covariates between the preterm and term deliveries, women with PCOS who delivered preterm had notably higher AMH than their term counterparts (11.1 vs. 5.4 ng/mL). In the univariate logistic regression analysis, each unit increase in AMH raised the odds of preterm delivery by 14% (odds ratio 1.14, 95% confidence interval 1.02-1.26). The effect was magnified only after adjusting for age, race, body mass index, smoking status, testosterone, homeostatic model assessment for insulin resistance, and treatment randomization group (adjusted odds ratio 1.25, 95% confidence interval 1.06-1.49). Unlike in the PCOS population, the unexplained infertility cohort had no significant difference in AMH levels between those with or without preterm delivery (2.3 vs. 2.6 ng/mL). CONCLUSIONS: Our findings suggest that women with PCOS and high AMH who conceived after ovulation induction represent a high-risk group for preterm delivery. These data indicate that closer monitoring in the third trimester of pregnancies in PCOS patients with early first trimester AMH levels above 9.3 ng/mL may be warranted. CLINICAL TRIAL REGISTRATION NUMBER: NCT01044862.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Kaing A, Jaswa EA, Diamond MP, et al. Highly elevated level of antimüllerian hormone associated with preterm delivery in polycystic ovary syndrome patients who underwent ovulation induction. Fertil Steril. 2020. PMID: 32883514. doi:10.1016/j.fertnstert.2020.06.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。